Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications
2009556 citationsLynch Ht, P. M. Lynch et al.Clinical Geneticsprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of S. J. Lanspa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. J. Lanspa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. J. Lanspa more than expected).
This network shows the impact of papers produced by S. J. Lanspa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. J. Lanspa. The network helps show where S. J. Lanspa may publish in the future.
Co-authorship network of co-authors of S. J. Lanspa
This figure shows the co-authorship network connecting the top 25 collaborators of S. J. Lanspa.
A scholar is included among the top collaborators of S. J. Lanspa based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with S. J. Lanspa. S. J. Lanspa is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Lynch, Henry T., et al.. (1990). Familial pancreatic cancer (Part II): Surveillance, diagnostic tests, and surgical strategies.. PubMed. 75(6). 130–3.2 indexed citations
14.
Lynch, Henry T., Mary Lee Fitzsimmons, T. C. Smyrk, et al.. (1990). Familial pancreatic cancer: clinicopathologic study of 18 nuclear families.. PubMed. 85(1). 54–60.104 indexed citations
15.
Lynch, Henry T., et al.. (1989). Familial pancreatic cancer (Part 1): Genetic pathology review.. PubMed. 74(5). 109–12.34 indexed citations
16.
Lynch, Henry T., T. C. Smyrk, S. J. Lanspa, et al.. (1988). Pathology and genetic markers of colorectal cancer in Lynch syndromes I and II. 3(4). 341–350.4 indexed citations
17.
Lynch, Henry T., Patrice Watson, S. J. Lanspa, et al.. (1988). Clinical nuances of Lynch syndromes I and II.. PubMed. 279. 177–88.3 indexed citations
18.
Lynch, Henry T., Thomas C. Smyrk, S. J. Lanspa, et al.. (1988). Flat Adenomas in a Colon Cancer-Prone Kindred1. JNCI Journal of the National Cancer Institute. 80(4). 278–282.89 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.